CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 116 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$74,000
-51.3%
27,558
-21.3%
0.00%
Q4 2021$152,000
-61.5%
35,036
-54.9%
0.00%
-100.0%
Q3 2021$395,000
-30.3%
77,610
-13.4%
0.00%0.0%
Q2 2021$567,000
-21.0%
89,596
-3.6%
0.00%0.0%
Q1 2021$718,000
+61.0%
92,906
+36.4%
0.00%0.0%
Q4 2020$446,000
-1.5%
68,1010.0%0.00%0.0%
Q3 2020$453,000
-20.0%
68,101
+0.1%
0.00%0.0%
Q2 2020$566,000
+8.4%
68,0070.0%0.00%0.0%
Q1 2020$522,000
-10.5%
68,007
-3.1%
0.00%0.0%
Q4 2019$583,000
+12.5%
70,1630.0%0.00%0.0%
Q3 2019$518,000
-33.4%
70,163
+1.2%
0.00%
-50.0%
Q2 2019$778,000
+5.4%
69,325
+1.0%
0.00%0.0%
Q1 2019$738,000
-29.2%
68,647
-0.5%
0.00%0.0%
Q4 2018$1,042,000
-17.3%
68,994
+1.3%
0.00%0.0%
Q3 2018$1,260,000
-6.6%
68,093
+15.4%
0.00%
-33.3%
Q2 2018$1,349,000
+7.1%
59,017
+33.4%
0.00%0.0%
Q1 2018$1,259,000
+30.2%
44,244
-3.4%
0.00%
+50.0%
Q4 2017$967,000
+14.6%
45,795
-1.4%
0.00%0.0%
Q3 2017$844,000
+5.9%
46,446
-9.7%
0.00%0.0%
Q2 2017$797,000
+14.7%
51,430
+27.8%
0.00%
+100.0%
Q1 2017$695,000
+50.4%
40,230
-4.3%
0.00%0.0%
Q4 2016$462,000
-31.7%
42,030
-2.6%
0.00%0.0%
Q3 2016$676,000
+54.3%
43,130
+0.7%
0.00%0.0%
Q2 2016$438,000
+109.6%
42,830
+164.0%
0.00%
Q1 2016$209,000
-29.4%
16,223
+14.2%
0.00%
-100.0%
Q4 2015$296,00014,2000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,500,000$7,635,0001.78%
Altium Capital Management LP 1,233,642$6,279,0001.65%
RA Capital Management 3,500,000$17,815,0000.25%
Soleus Capital Management, L.P. 261,050$1,329,0000.21%
Affinity Asset Advisors, LLC 125,000$636,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 1,078,103$5,488,0000.16%
Point72 Asset Management, L.P. 6,303,025$32,082,0000.14%
GSA CAPITAL PARTNERS LLP 249,146$1,268,0000.13%
Candriam S.C.A. 3,305,940$16,826,0000.11%
RTW INVESTMENTS, LP 1,400,939$7,131,0000.11%
View complete list of CYTOMX THERAPEUTICS INC shareholders